Quantitation of Plasma Levels of Tetranectin - Effects of Oral Contraceptives, Pregnancy, Treatment with L-Asparaginase and Liver Cirrhosis

Summary

Tetranectin is a tetrameric protein that binds to kringle 4 of plasminogen. Increase of electrophoretic mobility of the otherwise slowly migrating tetranectin in the presence of ethylenediaminetetraacetate was used to develop a reproducible electroimmunoassay to quantify plasma levels. Plasma levels in normals were found within narrow limits of 100 ± 16 (SD)%, (100% =0.15 pmol/1). There was no difference between males and females, smokers and non-smokers, and there were no significant changes with age from 20 to 49 years.

Patients with severe liver cirrhosis showed a large variation in plasma tetranectin levels but no systematic or average reduction, in contrast to strong reductions in plasma levels of other proteins. Patients treated with L-asparaginase showed a gradual reduction in time in plasma levels of various proteins, though tetranectin showed no significant reduction.

It is concluded that tetranectin can be assayed reproducibly in plasma and has a well regulated plasma level. This level is not sensitive to conditions with reductions in synthesis of many proteins, such as during cirrhosis of the liver and during L-asparaginase therapy. The reductions in plasma levels during the use of oral contraceptives and pregnancy indicate involvement of sex steroids in the metabolism of tetranectin.

Keywords

Fibrinolysis - Plasminogen - Tetranectin - Kringle 4 - L-asparaginase - Liver disease - Oral contraceptives - Pregnancy

• References

• 1 Danø K, Andreasen PA, Grøndahl-Hansen J, Kristensen P, Nielsen LS, Skriver L. Plasminogen activators, tissue degradation, and cancer. Adv Cancer Res 1985; 44: 139-266
• 2 Bachmann FFibrinolysis. In: Thrombosis and Haemostasis 1987. Verstraete M, Vermylen J, Lijnen HR, Amout J. (eds) International Society on Thrombosis and Haemostasis and Leuven University Press; Leuven: 1987: 227-265
• 3 Magnussen S, Sottrup-Jensen L, Petersen TE, Dudek-Wojciechowska G, Glaeys H. Homologous “kringle” structures common to plasminogen and prothrombin. Substrate specificity of enzymes activating prothrombin and plasminogen. In: Proteolysis and Physiological Regulation. Ribbons DW, Brew K. (eds) Academic Press; New York: 1976: 203-238
• 4 Günzler WA, Steffens GJ, Otting F, Kim S-MA, Frankus E, Flohe L. The primary structure of high molecular mass urokinse from human urine. Hoppe-Seylers Z Physiol Chem 1982; 363: 1155-1165
• 5 Pennica D, Holmes WE, Kohr WJ, Harkins RN, Vehar GA, Ward CA, Bennett WF, Yelverton E, Seeburg PH, Heyneker HL, Goeddel DV, Collen D. Cloning and expression of human tissue-type plasminogen activator cDNA in E. coli. . Nature 1983; 301: 214-221
• 6 Cool DE, Edgell C-JS, Louie GV, Zoller MJ, Brayer GD, MacGillivray RT A. Characterization of human blood coagulation factor XII cDNA. Prediction of the primary structure of factor XII and the tertiary structure of b-factor XII a. J Biol Chem 1985; 260: 13666-13676
• 7 Eaton DL, Fless GM, Kohr WJ, McLean JW, Xu QT, Miller CG, Lawn RM, Scanu AM. Partial amino acid sequence of apolipoprotein (a) shows that it is homologous to plasminogen. Proc Natl Acad Sci USA 1987; 84: 3224-3228
• 8 Clemmensen I, Petersen LC, Kluft C. Purification and characterization of a novel, oligomeric, plasminogen kringle 4 binding protein from human plasma: tetranectin. Eur J Biochem 1986; 156: 327-333
• 9 Jensen BA, McNair P, Hyldstrup L, Clemmensen I. Plasma tetranectin in healthy male and female individuals, measured by enzyme-linked immunosorbent assay. J Lab Clin Med 1987; 110: 612-617
• 10 Fuhlendorff J, Clemmensen I, Magnusson S. The primary structure of kringle 4 binding protein: tetranectin. Homology with asialoglycoprotein receptors and proteoglycan core protein. Biochemistry 1987; 26: 6757-6764
• 11 Laurell CB. Quantitative estimation of proteins by electrophoresis in agarose gel containing antibodies. Anal Biochem 1966; 15: 45-52
• 12 Deutch DG, Mertz ET. Plasminogen: purification from plasma by affinity chromatography. Science 1970; 170: 1095-1096
• 13 Kluft C, Brakman P, Veldhuyzen-Stolk EC. Screening of fibrinolytic activity in plasma euglobulin fractions on the fibrin plate. In: Progress in Chemical Fibrinolysis and Thrombolysis. Davidson JF, Samama MM, Desnoyers PC. (eds) Raven Press; New York: 1976. (; 2). 57-65
• 14 Weeke B. Crossed immunoelectrophoresis. In: A Manual of Quantitative Immunoelectrophoresis. Axelsen NH, Krøll J, Weeke B. (eds) Universitets Forlaget; Oslo: 1973: 47-56
• 15 Gevers Leuven JA, Kluft C, Bertina RM, Hessel LW. Effect of two low-dose oral contraceptives on circulating components of the coagulation and fibrinolytic systems. J Lab Clin Med 1987; 109: 631-636
• 16 Boks AL, Brommer EJ P, Schalm SW, van Vliet HH D M. Hemostasis and fibrinolysis in severe liver failure and their relation to hemorrhage. Hepatology 1986; 6: 79-86
• 17 Kahlé LH, Schipper HG, Jenkins CS P, Ten Cate JW. Antithrombin III: Evaluation of an automated antithrombin III method. Thromb Res 1978; 12: 1003-1014
• 18 Friberger P, Knos M, Gustavsson S, Aurell L, Claeson G. Methods for determination of plasmin, antiplasmin and plasminogen by means of substrate S-2251. Haemostasis 1978; 7: 138-145
• 19 Clauss A. Gerinnungsphysiologische Schnellmethode zur Bestimmung des Fibrinogens. Acta Haematol 1957; 17: 237-246
• 20 Kluft C, Preston FE, Malia RG, Bertina RM, Wijngaards G, Greaves M, Verheijen JH, Dooijewaard G. Stanozolol-induced changes in fibrinolysis and coagulation in healthy adults. Thromb Haemostas 1984; 51: 157-164
• 21 Vellenga E, Kluft C, Mulder NH, Wijngaards G, Nieweg HO. The influence of L-asparaginase therapy on the fibrinolytic system. Br J Haematol 1984; 57: 247-254
• 22 Vellenga E, Broekmans AW, Kluft C. Thrombotic complications during L-asparaginase related to protein C deficiency?. Thromb Haemostas 1985; 53: 443
• 23 Kluft C, Svendsen L, Los P. Direct assay of factor XII a in plasma with synthetic chromogenic substrates. In: Kinins-III: Advances in experimental medicine and biology. Fritz H, Back N, Dietze G, Haberland GL. (eds) Plenum Press; New York: 1983. (; 156A). 201-204
• 24 Kluft C. Determination of prekallikrein in human plasma: optimal conditions for activating prekallikrein. J Lab Clin Med 1978; 91: 83-95
• 25 Kluft C, Los P, Clemmensen I. Immunological studies on a plasminogen-kringle 4 binding protein in plasma. Thromb Haemostas 1985 54: 277 (Abstract 01642)
• 26 Kluft C, Los P, Clemmensen I. Calcium-dependent binding of tetranectin to fibrin. Thromb Res. 1988. in press.
• 27 Allen RA, Kluft C, Brommer EJ P. Effect of chronic smoking on fibrinolysis. Arteriosclerosis 1985; 5: 443-450
• 28 Pugh RN H, Murray-Lyon IM, Dawson JL. Transection of the oesophagus for bleeding oesophageal varices. Br J Surg 1973; 60: 646-649